Based in Bloomington, MN, MGi Pharma (MGi) is an oncology-focused biopharmaceutical Company. The Company acquires, develops, and markets specialty pharmaceutical and medical products for markets of unmet needs.
The Winning Solution
MGi was seeking new therapeutic drugs in development to purchase, continue research, finalize development, and ultimately commercialize for consumer sales. Mgi is focused on cancer drugs and targeted Zycos for their cancer and antiviral therapeutics. The principals of Genoa Partners help MGi purchase Zycos for $50 million.
Based in Lexington, MA, Zycos is a drug development company focused on converting genetic information into novel therapeutics.